New Migraine Research Study

Currently Enrolling

Do you suffer from migraines?

Migraine is a huge problem affecting more than 37 million Americans.  According to the World Health Organization (WHO), migraine is the third most common disease and the sixth most disabling.  Are you struggling to manage them?

If your migraine lasts three or more hours if not treated, don’t settle.  Participate in a research study and help
us learn more about a new investigational medication. 

Who is eligible to participate?

You may be eligible to participate if you are:

  • 18-65 years of age
  • Suffering with at least 2 moderate to severe migraine attacks per month

What does the study involve?

There are three visits to our office over a 13-week period. You will be provided either a placebo (inactive ingredient), a FDA approved medication or an investigational medication for the treatment of a single migraine.  Study related office visits, laboratory work and research medication are provided at no cost.  Compensation for time and travel is available.

How to participate?

For more information about the potential benefits and risks and to see if you may be eligible to participate, send an email inquiry, call 615-329-2222 or click the Participate button at the top right.